View Cart (0 items)

Pharmaceutical

Pharmaceutical industry leaders to examine global supply network challenges, solutions at ISPE Conference

No Comments
TAMPA, Fla. — ISPE will host an in-depth two-day conference that will bring together top industry leaders and regulators to examine global supply network challenges and solutions. The event, “Designing,
Read More

Multi-tasking Titrator

No Comments
JM Science’s Potentiometric Titrator (COM-1700) can run four titrations and stirrers that easily allow end user to do different types of titration including potentiometric, photometric, polarization, and conductometric titrations in
Read More

Pfizer, BYU settle Celebrex lawsuit for $450M

No Comments
One month from trial date, Brigham Young University and Pfizer Inc. settled a lawsuit Tuesday for $450 million over whether the Utah school had been cheated out of billions of
Read More

Novartis to Buy Fougera Pharmaceuticals for $1.5 Billion

No Comments
Novartis International has agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, for $1.525 billion in cash, reported by The New York Times. Under the terms of
Read More

Pfizer Q1 profit falls 19 percent

No Comments
The Associated Press reports, Pfizer Inc. said Tuesday that its first-quarter profit fell 19 percent, mainly because new generic competition to its blockbuster cholesterol pill Lipitor cut U.S. sales by
Read More

Warner Chilcott to explore sale of company

No Comments
Specialty pharmaceutical company Warner Chilcott Plc said it would explore strategic options, including preliminary talks with potential buyers, Reuters reports. The company said it hired Goldman Sachs as its financial
Read More

Bayer sues generic drug maker over erectile dysfunction drug

No Comments
WILMINGTON, Del. — Bayer Pharma AG is suing generic drug maker Watson Pharmaceuticals Inc. for allegedly infringing two U.S. patents for the erectile dysfunction drug Staxyn, Bloomberg reported. Bayer
Read More

Pfizer to sell infant nutrition unit

No Comments
NEW YORK — Pfizer Inc. has decided to sell its infant nutrition business as soon as next week, The New York Times reported. According to the story, Nestle appears
Read More

Idaho settles GlaxoSmithKline case for $2.6 million

No Comments
BOISE, Idaho — Drugmaker GlaxoSmithKline has agreed to pay the state of Idaho $2.6 million to settle allegations that the company sold products at false or inflated prices, CNBC
Read More

J&J fined $1.1 billion in antipsychotic drug case

No Comments
LITTLE ROCK, Ark. — An Arkansas judge ordered Johnson & Johnson to pay more than $1.1 billion in fines after a jury found the company’s officials misled doctors and
Read More